Results 251 to 260 of about 177,679 (314)
Enhancing LI-RADS Through Semi-Automated Quantification of HCC Lesions. [PDF]
Jöbstl A +6 more
europepmc +1 more source
Rounded TiO2 nanoparticles we sucesfully synthesized with modulated sizes from 109 to 22 nm. We observed the WS2 and NiWS active phases forming parallel slabs to the surface. The presence of Ni helped W to be better dispersed, especially on the smallest nanoparticles, which resulted in the highest activity detected among the series.
Eduardo D. Gutiérrez‐López +7 more
wiley +1 more source
Optimized quantum folding Barrett reduction for quantum modular multipliers. [PDF]
Zhang J, Cho SM, Lee C, Seo SH.
europepmc +1 more source
Fine Tuning of Surface Structures by Soft‐Template Electropolymerization
Nanotubes are formed by soft‐template electropolymerization in solvent of low water‐solubility but especially using one of the two tested stereoisomers of benzodithiophene and using an interfacially more active electrolyte with long alkyl chains (tetrahexylammonium perchlorate).
Salihu Dihissu +9 more
wiley +1 more source
Effect of Micro‐ and Nanomorphology of Carbon Nanotube Electrochemical Electrodes on Virus Sensing
Carbon nanotubes (CNTs), which have high electrical conductivity and antibody modification, have been shown to be the optimal structure for electrochemical electrodes. Highly sensitive detection of norovirus with a detection limit of 1 fg mL−1 is achieved. This research which clarified the relationship between CNT structure and electrochemical reaction,
Daichi Suzuki +2 more
wiley +1 more source
The Role of Executive Function in the Co-occurrence of ADHD and Developmental Dyscalculia in Chinese Children. [PDF]
Zhang J +6 more
europepmc +1 more source
Abstract AZD7442, a combination of extended half‐life monoclonal antibodies tixagevimab and cilgavimab, was shown to neutralize previously circulating SARS‐CoV‐2 variants. This study evaluated safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD7442 in healthy Chinese adults. In this randomized, placebo‐controlled, Phase 1 study, AZD7442
Nanyang Li +11 more
wiley +1 more source
Abstract Zanubrutinib is a next‐generation Bruton tyrosine kinase inhibitor approved for treating B‐cell malignancies. Two phase 1 studies evaluated a new 160‐mg zanubrutinib tablet versus 80‐mg capsules. In study BGB‐3111‐115 (n = 43), a randomized 3‐period crossover trial, relative bioavailability and food effects were assessed.
Bilal Tariq +5 more
wiley +1 more source
Deciphering corneal astigmatism: calculation pitfalls and how to avoid them. [PDF]
Langenbucher A +10 more
europepmc +1 more source

